Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Cancer Medicine|February 28, 2014
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancerYingmiao Liu, Mark D Starr, John C Brady, et al.
Journal of Periodontology|June 22, 2021
Microvesicles, blood cells, and endothelial cells mediate phosphatidylserine-related prothrombotic state in patients with periodontitisNan Zuo, Wenhui Liu, Tenglong Hu, et al.
Orphanet Journal of Rare Diseases|September 4, 2021
Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformationsSarah E Wetzel-Strong, Shantel Weinsheimer, Jeffrey Nelson, et al.
Ebiomedicine|March 2, 2020
Interactions between neutrophil extracellular traps and activated platelets enhance procoagulant activity in acute stroke patients with ICA occlusionPeng Zhou, Tao Li, Jiaqi Jin, et al.
Molecular Cancer Therapeutics|February 20, 2015
Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimusYingmiao Liu, Mark D Starr, John C Brady, et al.
Neuro-Oncology|April 6, 2017
The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survivalEric M Thompson, Stephen T Keir, Talaignair Venkatraman, et al.
Prostate Cancer and Prostatic Diseases|February 12, 2024
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumabAndrew B Nixon, Yingmiao Liu, Qian Yang, et al.
ACS Synthetic Biology|June 20, 2020
Multicopy Chromosomal Integration Using CRISPR-Associated TransposasesYiwen Zhang, Xiaoman Sun, Qingzhuo Wang, et al.
Research Square|January 7, 2025
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responsesAndrew B Nixon, Fábio C P Navarro, Katherine I Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2007
RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicinJing Mi, Xiuwu Zhang, Zahid N Rabbani, et al.
Pageof 6